abstract |
The present invention relates to the use of an agent, inhibitor of the expression and/or activity of ADAM-17, in the preparation of a drug or pharmaceutical composition to increase the neural regeneration in injuries of the mammalian nervous system, preferably human, in need of said treatment. |